Abstract
The immune system is a sophisticated and complex system that is influenced by various exogenous insults such as surgical stress and endogenous factors like the sympathetic nervous system. It has been demonstrated that sedative agents used in clinical practice alter the balance of pro- and anti-inflammatory cytokines. These effects may be reversible following short exposure to anaesthetic agents and sedative drugs. However, many critically ill patients are sedated for prolonged periods of time, which raises concerns about the risks of immunological interference by sedative agents. When one considers that sepsis accounts for significant morbidity in intensive care, it is imperative that anything modifiable which causes immunosuppression is identified. The systemic inflammatory response syndrome is known to feature an increase in pro-inflammatory mediators, something which could be influenced by sedative agents.
We propose to outline the details surrounding this area, focusing on sedative agents commonly used in the intensive care setting. A more detailed understanding of this area could lead to improved patient outcomes and have far-reaching influence on clinical practice in critical care.
Keywords: Critical care, sedation, immunosuppression, immunomodulation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: The Immunological Side-Effects of Sedative Agents in the Intensive Care Unit
Volume: 9 Issue: 3
Author(s): A. Walsh and K. Ghori
Affiliation:
Keywords: Critical care, sedation, immunosuppression, immunomodulation
Abstract: The immune system is a sophisticated and complex system that is influenced by various exogenous insults such as surgical stress and endogenous factors like the sympathetic nervous system. It has been demonstrated that sedative agents used in clinical practice alter the balance of pro- and anti-inflammatory cytokines. These effects may be reversible following short exposure to anaesthetic agents and sedative drugs. However, many critically ill patients are sedated for prolonged periods of time, which raises concerns about the risks of immunological interference by sedative agents. When one considers that sepsis accounts for significant morbidity in intensive care, it is imperative that anything modifiable which causes immunosuppression is identified. The systemic inflammatory response syndrome is known to feature an increase in pro-inflammatory mediators, something which could be influenced by sedative agents.
We propose to outline the details surrounding this area, focusing on sedative agents commonly used in the intensive care setting. A more detailed understanding of this area could lead to improved patient outcomes and have far-reaching influence on clinical practice in critical care.
Export Options
About this article
Cite this article as:
Walsh A. and Ghori K., The Immunological Side-Effects of Sedative Agents in the Intensive Care Unit, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2010; 9 (3) . https://dx.doi.org/10.2174/1871523011009030229
DOI https://dx.doi.org/10.2174/1871523011009030229 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Herbal and Traditional Chinese Medicine for the Treatment of Cardiovascular Complications in Diabetes Mellitus
Current Diabetes Reviews Current Drug Targets and Future Therapy of Pulmonary Arterial Hypertension
Current Medicinal Chemistry Calcium Related Genes in Dogs as Potential Cardiac Biomarkers for the Detection of Chronic Mitral Valve Disease
Recent Patents on Biomarkers Emerging Therapy for Diabetic Neuropathy: Cell Therapy Targeting Vessels and Nerves
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of ARBs in the Blood Hypertension Therapy and Prevention of Cardiovascular Events
Current Drug Targets Quick-Release Bromocriptine for Treatment of Type 2 Diabetes
Current Drug Delivery Chalcones as Versatile Synthons for the Synthesis of 5- and 6-membered Nitrogen Heterocycles
Current Organic Chemistry Pharmacological Treatment of ADHD and the Short and Long Term Effects on Sleep
Current Pharmaceutical Design Update on Diagnostic and Treatment of Uncomplicated and Complicated Malaria in Adults and Selected Vulnerable Populations
Infectious Disorders - Drug Targets Phosphodiesterase 5 Inhibitors - Drug Design and Differentiation Based on Selectivity, Pharmacokinetic and Efficacy Profiles
Current Pharmaceutical Design Cardiovascular Alterations After Spinal Cord Injury: An Overview
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Guanylation of Amines with Isonitriles in the Presence of Iodine
Letters in Organic Chemistry Non-Analgesic Effects of Opioids: Neuroprotection in the Retina
Current Pharmaceutical Design Antiatherosclerotic and Cardioprotective Effects of Time-Released Garlic Powder Pills
Current Pharmaceutical Design Pharmacology of Ivabradine and the Effect on Chronic Heart Failure
Current Topics in Medicinal Chemistry Urtica dioica in the Management of Benign Prostate Hyperplasia (BPH)
The Natural Products Journal Heart Failure in Acute Ischemic Stroke
Current Cardiology Reviews Electroporation in DNA Vaccination Protocols Against Cancer
Current Drug Metabolism Targeting Trypanosoma cruzi Platelet-activating Factor Receptors: Scope for the Development of Novel Drugs to Treat Chagas Disease
Mini-Reviews in Medicinal Chemistry Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
Current Neuropharmacology